Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

October 27, 2021

Study Completion Date

January 17, 2022

Conditions
Parenteral NutritionInfant, Premature, DiseasesInfant, Newborn, DiseaseLung DiseasesRespiratory Tract DiseaseBronchopulmonary DysplasiaPathologic Processes
Interventions
OTHER

Photo-protection

The MV solution is delivered from producing companies in amber vials. The MV will be sampled by the pharmacy technician in a syringe that is photo-protected with a white label indicating the subject study name, protocol number and the infusion rate. The MV will be transported to the unit in the same photo-protected syringe. In the neonatal unit, this syringe will be installed in the pump and connected to photo-protected extension duration.

OTHER

Standard Care

This group will receive the standard practice of PN compounding in the pharmacy followed by infusion in standard infusion kit available in Sainte-Justine's Hospital.

Trial Locations (2)

H3T 1C5

CHU Sainte-Justine, Montreal

Unknown

University of Montreal, Sainte-Justine Hospital, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER

NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study | Biotech Hunter | Biotech Hunter